ng, developing and commercializing innovative products to meet
unmet medical needs in neurology and psychiatry. For further information,
please visit
http://www.JazzPharmaceuticals.com.
Contacts:
Jazz Pharmaceuticals, Inc.
Jim Karrels
Executive Director, Finance
650-496-2800
investorinfo@jazzpharma.com
BCC Partners
Karen L. Bergman, 650-575-1509
Michelle Corral, 415-794-8662
'/>"/>SOURCE Jazz Pharmaceuticals, Inc. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Speaker announces business members of IT Task Force2.
Doyle announces technology tax credits for Berbee3.
Doyle announces new energy, global warming policies4.
Doyle, WARF announce partnership to lure stem cell companies5.
Doyle announces $80M renewable energy strategy6.
GE announces first installation of Discovery VCT7.
UWM announces winners of RGI awards8.
Third Wave announces two senior management appointments9.
Mirus announces new method for making antibodies10.
Merge announces sofware updates, upcoming acquisition11.
Small Tree announces ethernet solution for Apple Xserv G5